Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mazza

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Haematologica|November 1, 1989
A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage II-IV diffuse non-Hodgkin's lymphomasC Guglielmi, F Gherlinzoni, S Amadori, et al.
Haematologica|November 1, 1992
Hodgkin's disease: summary of twenty years' experienceP Mazza, M Bocchia, P L Zinzani, et al.
AIDS (London, England)|June 1, 1993
Recombinant alpha-interferon 2b in the treatment of HIV-related thrombocytopeniaN Vianelli, L Catani, L Gugliotta, et al.
Blood|January 15, 1997
3'-Azido 3'-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomasP Tosi, F Gherlinzoni, P Mazza, et al.
Minerva Anestesiologica|March 1, 1993
[Drepanocytosis in patients undergoing heart surgery. Anesthesiologic problems]P Ceriana, M Maurelli, F Pagani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group reportA M Carella, A M Congiu, E Gaozza, et al.
Haematologica|November 1, 1988
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignanciesS Tura, P Mazza, F Gherlinzoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomasS Tura, P Mazza, F Gherlinzoni, et al.
Haematologica|July 1, 1987
Clinicopathological study on non-Hodgkin's lymphomasP Mazza, F Gherlinzoni, G Kemna, et al.
Leukemia & Lymphoma|February 1, 1995
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomasP Mazza, P L Zinzani, M Martelli, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Haematologica|November 1, 1989
A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage II-IV diffuse non-Hodgkin's lymphomasC Guglielmi, F Gherlinzoni, S Amadori, et al.
Haematologica|November 1, 1992
Hodgkin's disease: summary of twenty years' experienceP Mazza, M Bocchia, P L Zinzani, et al.
AIDS (London, England)|June 1, 1993
Recombinant alpha-interferon 2b in the treatment of HIV-related thrombocytopeniaN Vianelli, L Catani, L Gugliotta, et al.
Blood|January 15, 1997
3'-Azido 3'-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomasP Tosi, F Gherlinzoni, P Mazza, et al.
Minerva Anestesiologica|March 1, 1993
[Drepanocytosis in patients undergoing heart surgery. Anesthesiologic problems]P Ceriana, M Maurelli, F Pagani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group reportA M Carella, A M Congiu, E Gaozza, et al.
Haematologica|November 1, 1988
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignanciesS Tura, P Mazza, F Gherlinzoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomasS Tura, P Mazza, F Gherlinzoni, et al.
Haematologica|July 1, 1987
Clinicopathological study on non-Hodgkin's lymphomasP Mazza, F Gherlinzoni, G Kemna, et al.
Leukemia & Lymphoma|February 1, 1995
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomasP Mazza, P L Zinzani, M Martelli, et al.
Pageof 18